Profile data is unavailable for this security.
About the company
Mabion SA is a Poland-based biopharmaceutical company. The Company provides a broad spectrum of services in the segment of small and medium-sized projects at various stages of development (from early-stage discovery to commercial manufacturing). The Company's competencies include the selection of protein expression technologies, their purification, GMP-standard manufacturing activities (obtaining Active Substances - Drug Substance and Finished Products - Drug Product), development of analytical tools (for structural, functional, physicochemical characterization), clinical development, clinical analytics and a full range of regulatory activities in the development and operational areas. The Company's goal is to establish itself as a recognizable player in the global contract manufacturing and contract drug development market and to complete its full transformation into an integrated biologics CDMO company.
- Revenue in PLN (TTM)139.86m
- Net income in PLN37.39m
- Incorporated2009
- Employees226.00
- LocationMabion SAgen. Mariana Langiewicza 60KONSTANTYNOW LODZKI 95-050PolandPOL
- Phone+48 422077890
- Fax+48 422032703
- Websitehttps://www.mabion.eu/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Read Gene SA | 11.63m | -1.00m | 66.97m | 11.00 | -- | 35.89 | -- | 5.76 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
Pure Biologics SA | 68.00k | -23.01m | 68.31m | 11.00 | -- | -- | -- | 1,004.63 | -7.09 | -8.27 | 0.0211 | -1.82 | 0.0016 | -- | 0.469 | 1,333.33 | -53.52 | -65.91 | -85.74 | -109.50 | -1,457.35 | 6.97 | -33,838.23 | -487.38 | -- | -7.36 | -- | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
Sds Optic SA | 370.00 | -8.98m | 78.17m | -- | -- | -- | -- | 211,274.10 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
Genomtec SA | 2.00k | -11.00m | 90.34m | -- | -- | 7.69 | -- | 45,170.31 | -0.8971 | -0.8971 | 0.0002 | 0.9582 | 0.00009 | 62.24 | 0.0011 | -- | -47.25 | -- | -60.10 | -- | -115,050.00 | -- | -549,850.00 | -- | 2.06 | -88.39 | 0.1442 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
Nanogroup SA | 1.02k | -7.12m | 98.50m | -- | -- | 12.24 | -- | 96,570.91 | -0.3541 | -0.3541 | 0.00005 | 0.3253 | 0.00007 | 7.84 | 0.0141 | -- | -45.22 | -23.18 | -51.42 | -26.06 | -99,397.06 | -278.03 | -692,468.60 | -1,567.57 | 2.75 | -858.81 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
Urteste SA | 0.00 | -4.28m | 132.51m | -- | -- | 5.12 | -- | -- | -3.15 | -3.15 | 0.00 | 18.34 | 0.00 | 11.94 | -- | -- | -14.28 | -- | -14.78 | -- | -- | -- | -- | -- | 17.80 | -- | 0.026 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
Molecure SA | 355.10k | -25.51m | 179.47m | 113.00 | -- | 2.08 | -- | 505.41 | -1.52 | -1.52 | 0.0211 | 5.13 | 0.0032 | -- | 0.4907 | 3,199.10 | -22.88 | 2.64 | -23.91 | 2.76 | -542.79 | 97.54 | -7,184.10 | 12.84 | -- | -- | 0.0657 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
Poltreg SA | 600.00k | -17.42m | 250.89m | 23.00 | -- | 3.16 | -- | 418.16 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
Mabion SA | 139.86m | 37.39m | 260.86m | 226.00 | 6.98 | 1.79 | 5.66 | 1.87 | 2.31 | 2.31 | 8.65 | 9.01 | 0.7538 | 4.02 | 17.35 | 618,836.30 | 20.15 | -7.19 | 25.09 | -16.79 | 78.30 | 58.10 | 26.73 | -14.27 | 1.64 | 101.63 | 0.026 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
BIOTON SA | 186.32m | -6.85m | 286.79m | 358.00 | -- | 0.4791 | 11.13 | 1.54 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
Captor Therapeutics SA | 18.64m | -46.69m | 331.06m | 104.00 | -- | 6.53 | -- | 17.76 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
Scope Fluidics SA | 98.00k | -26.68m | 444.33m | 40.00 | -- | 6.58 | -- | 4,533.95 | -9.79 | -9.79 | 0.036 | 24.76 | 0.001 | 2.53 | 0.0716 | 2,450.00 | -27.04 | 52.74 | -28.55 | 57.32 | -2,013.27 | -420.87 | -27,227.55 | 30,134.78 | 11.32 | -- | 0.0301 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
Selvita SA | 329.02m | 47.40m | 1.05bn | 382.00 | 22.07 | 3.31 | 10.85 | 3.18 | 2.58 | 2.58 | 17.93 | 17.22 | 0.5415 | 9.29 | 4.44 | 388,455.70 | 7.80 | -- | 9.35 | -- | 78.69 | -- | 14.41 | -- | 1.06 | -0.1509 | 0.4236 | -- | -3.48 | -- | 130.55 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Generali PTE SAas of 29 Dec 2023 | 359.99k | 2.23% |
Investors TFI SAas of 31 Dec 2023 | 197.37k | 1.22% |
SSgA Funds Management, Inc.as of 03 Jul 2024 | 16.82k | 0.10% |
IPOPEMA TFI SAas of 30 Jun 2023 | 1.67k | 0.01% |
PKO TFI SAas of 31 May 2024 | 222.00 | 0.00% |
Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 31 Dec 2023 | 0.00 | 0.00% |